Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) kicked off on Friday, up 6.12% from the previous trading day, before settling in for the closing price of $11.11. Over the past 52 weeks, ARWR has traded in a range of $9.57-$30.41.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -2.87% over the past five years. While this was happening, its average annual earnings per share was recorded 47.20%. With a float of $114.16 million, this company’s outstanding shares have now reached $125.57 million.
Let’s look at the performance matrix of the company that is accounted for 609 employees. In terms of profitability, gross margin is -272.28%, operating margin of -25037.88%, and the pretax margin is -25870.12%.
Arrowhead Pharmaceuticals Inc (ARWR) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Arrowhead Pharmaceuticals Inc is 16.87%, while institutional ownership is 70.67%. The most recent insider transaction that took place on Apr 11 ’25, was worth 583,692. In this transaction Chief Executive Officer of this company sold 50,800 shares at a rate of $11.49, taking the stock ownership to the 3,921,255 shares. Before that another transaction happened on Apr 10 ’25, when Company’s Chief Executive Officer sold 50,000 for $10.87, making the entire transaction worth $543,500. This insider now owns 3,972,055 shares in total.
Arrowhead Pharmaceuticals Inc (ARWR) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 47.20% per share during the next fiscal year.
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) Trading Performance Indicators
Take a look at Arrowhead Pharmaceuticals Inc’s (ARWR) current performance indicators. Last quarter, stock had a quick ratio of 6.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 647.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.15, a number that is poised to hit -0.44 in the next quarter and is forecasted to reach -3.66 in one year’s time.
Technical Analysis of Arrowhead Pharmaceuticals Inc (ARWR)
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) saw its 5-day average volume 2.93 million, a positive change from its year-to-date volume of 2.0 million. As of the previous 9 days, the stock’s Stochastic %D was 52.18%. Additionally, its Average True Range was 1.17.
During the past 100 days, Arrowhead Pharmaceuticals Inc’s (ARWR) raw stochastic average was set at 12.49%, which indicates a significant decrease from 37.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 107.48% in the past 14 days, which was higher than the 80.78% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $16.40, while its 200-day Moving Average is $20.76. Nevertheless, the first resistance level for the watch stands at $12.15 in the near term. At $12.50, the stock is likely to face the second major resistance level. The third major resistance level sits at $13.20. If the price goes on to break the first support level at $11.09, it is likely to go to the next support level at $10.39. The third support level lies at $10.04 if the price breaches the second support level.
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) Key Stats
The company with the Market Capitalisation of 1.62 billion has total of 137,317K Shares Outstanding. Its annual sales at the moment are 3,550 K in contrast with the sum of -599,490 K annual income. Company’s last quarter sales were recorded 2,500 K and last quarter income was -173,090 K.
